These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 38288121)

  • 21. Interferon induction, evasion, and paradoxical roles during SARS-CoV-2 infection.
    Chiale C; Greene TT; Zuniga EI
    Immunol Rev; 2022 Aug; 309(1):12-24. PubMed ID: 35775361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of SARS-CoV-2 by type I and type III interferons.
    Felgenhauer U; Schoen A; Gad HH; Hartmann R; Schaubmar AR; Failing K; Drosten C; Weber F
    J Biol Chem; 2020 Oct; 295(41):13958-13964. PubMed ID: 32587093
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SARS-CoV-2 ORF9b antagonizes type I and III interferons by targeting multiple components of the RIG-I/MDA-5-MAVS, TLR3-TRIF, and cGAS-STING signaling pathways.
    Han L; Zhuang MW; Deng J; Zheng Y; Zhang J; Nan ML; Zhang XJ; Gao C; Wang PH
    J Med Virol; 2021 Sep; 93(9):5376-5389. PubMed ID: 33913550
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SARS-CoV-2 Isolates Show Impaired Replication in Human Immune Cells but Differential Ability to Replicate and Induce Innate Immunity in Lung Epithelial Cells.
    Jiang M; Kolehmainen P; Kakkola L; Maljanen S; Melén K; Smura T; Julkunen I; Österlund P
    Microbiol Spectr; 2021 Sep; 9(1):e0077421. PubMed ID: 34378952
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SARS-CoV-2 infection activates a subset of intrinsic pathways to inhibit type I interferons
    Luo W; Huang L; Wang X; Ma Y; Xiao J; Song X; Liu P; Wang Y; Wang Y; Ren Z
    Int J Med Sci; 2021; 18(12):2561-2569. PubMed ID: 34104087
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential roles of interferons in innate responses to mucosal viral infections.
    Walker FC; Sridhar PR; Baldridge MT
    Trends Immunol; 2021 Nov; 42(11):1009-1023. PubMed ID: 34629295
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fortifying immunity: PLSCR1 picks battle against SARS-CoV-2.
    Li M
    Cell Host Microbe; 2023 Sep; 31(9):1417-1419. PubMed ID: 37708846
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elimination of Aicardi-Goutières syndrome protein SAMHD1 activates cellular innate immunity and suppresses SARS-CoV-2 replication.
    Oo A; Zandi K; Shepard C; Bassit LC; Musall K; Goh SL; Cho YJ; Kim DH; Schinazi RF; Kim B
    J Biol Chem; 2022 Mar; 298(3):101635. PubMed ID: 35085552
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interferon-Lambda Intranasal Protection and Differential Sex Pathology in a Murine Model of SARS-CoV-2 Infection.
    Sohn SY; Hearing J; Mugavero J; Kirillov V; Gorbunova E; Helminiak L; Mishra S; Mackow E; Hearing P; Reich NC; Kim HK
    mBio; 2021 Dec; 12(6):e0275621. PubMed ID: 34724828
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential interferon-α subtype induced immune signatures are associated with suppression of SARS-CoV-2 infection.
    Schuhenn J; Meister TL; Todt D; Bracht T; Schork K; Billaud JN; Elsner C; Heinen N; Karakoese Z; Haid S; Kumar S; Brunotte L; Eisenacher M; Di Y; Lew J; Falzarano D; Chen J; Yuan Z; Pietschmann T; Wiegmann B; Uebner H; Taube C; Le-Trilling VTK; Trilling M; Krawczyk A; Ludwig S; Sitek B; Steinmann E; Dittmer U; Lavender KJ; Sutter K; Pfaender S
    Proc Natl Acad Sci U S A; 2022 Feb; 119(8):. PubMed ID: 35131898
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Delayed induction of type I and III interferons mediates nasal epithelial cell permissiveness to SARS-CoV-2.
    Hatton CF; Botting RA; Dueñas ME; Haq IJ; Verdon B; Thompson BJ; Spegarova JS; Gothe F; Stephenson E; Gardner AI; Murphy S; Scott J; Garnett JP; Carrie S; Powell J; Khan CMA; Huang L; Hussain R; Coxhead J; Davey T; Simpson AJ; Haniffa M; Hambleton S; Brodlie M; Ward C; Trost M; Reynolds G; Duncan CJA
    Nat Commun; 2021 Dec; 12(1):7092. PubMed ID: 34876592
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clash of the titans: interferons and SARS-CoV-2.
    Jouvenet N; Goujon C; Banerjee A
    Trends Immunol; 2021 Dec; 42(12):1069-1072. PubMed ID: 34742657
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SARS-CoV-2 Nonstructural Protein 1 Inhibits the Interferon Response by Causing Depletion of Key Host Signaling Factors.
    Kumar A; Ishida R; Strilets T; Cole J; Lopez-Orozco J; Fayad N; Felix-Lopez A; Elaish M; Evseev D; Magor KE; Mahal LK; Nagata LP; Evans DH; Hobman TC
    J Virol; 2021 Jun; 95(13):e0026621. PubMed ID: 34110264
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of STING Signaling Pathway Effectively Blocks Human Coronavirus Infection.
    Liu W; Reyes HM; Yang JF; Li Y; Stewart KM; Basil MC; Lin SM; Katzen J; Morrisey EE; Weiss SR; You J
    J Virol; 2021 May; 95(12):. PubMed ID: 33789998
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SARS-CoV-2 Is Restricted by Zinc Finger Antiviral Protein despite Preadaptation to the Low-CpG Environment in Humans.
    Nchioua R; Kmiec D; Müller JA; Conzelmann C; Groß R; Swanson CM; Neil SJD; Stenger S; Sauter D; Münch J; Sparrer KMJ; Kirchhoff F
    mBio; 2020 Oct; 11(5):. PubMed ID: 33067384
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SARS-CoV-2 ORF6 protein does not antagonize interferon signaling in respiratory epithelial Calu-3 cells during infection.
    Li M; Ayyanathan K; Dittmar M; Miller J; Tapescu I; Lee JS; McGrath ME; Xue Y; Vashee S; Schultz DC; Frieman MB; Cherry S
    mBio; 2023 Aug; 14(4):e0119423. PubMed ID: 37377442
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SARS-CoV-2 ORF9b inhibits RIG-I-MAVS antiviral signaling by interrupting K63-linked ubiquitination of NEMO.
    Wu J; Shi Y; Pan X; Wu S; Hou R; Zhang Y; Zhong T; Tang H; Du W; Wang L; Wo J; Mu J; Qiu Y; Yang K; Zhang LK; Ye BC; Qi N
    Cell Rep; 2021 Feb; 34(7):108761. PubMed ID: 33567255
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanisms of Antiviral Immune Evasion of SARS-CoV-2.
    Beyer DK; Forero A
    J Mol Biol; 2022 Mar; 434(6):167265. PubMed ID: 34562466
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Innate immunity and interferon in SARS-CoV-2 infection outcome.
    Savan R; Gale M
    Immunity; 2023 Jul; 56(7):1443-1450. PubMed ID: 37437537
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevated temperature inhibits SARS-CoV-2 replication in respiratory epithelium independently of IFN-mediated innate immune defenses.
    Herder V; Dee K; Wojtus JK; Epifano I; Goldfarb D; Rozario C; Gu Q; Da Silva Filipe A; Nomikou K; Nichols J; Jarrett RF; Stevenson A; McFarlane S; Stewart ME; Szemiel AM; Pinto RM; Masdefiol Garriga A; Davis C; Allan J; Graham SV; Murcia PR; Boutell C
    PLoS Biol; 2021 Dec; 19(12):e3001065. PubMed ID: 34932557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.